WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

CONCEPT OF OJOKSHAYA IN IMMUNODEFICIENT DISORDERS

*Dr. Kumari Neelam and Dr. Ankita Yadav

Abstract

Ojas is the finest product of all seven dhatus and also the transformation of dhatwagnipaka. It is formed and transported through all the dhatuvaha srotas where it permeates the entire body. Acharya Sushruta has describe oja as bala which has similar qualities to the kapha and prakrut kapha is considered as oja. Ayurveda text describe ojokshaya as one of the ojovikara which means quantitatively or qualitatively or functionally deficiency of oja is called as oja kshaya which is diagnosed on the basis of symptoms. Acharya Sushrut describe the symptoms of ojokshaya as Murcha, Mansakshaya, Moha, Pralap, Mrityu. There are various conditions in which these entities are found like Sannipatajjawara, Pandu, Madhumeha, Shosha, Rajyakshma, Kshatkshin, Kshayaj grahani, Madatya and in AIDS etc. Immunodeficient disorders or immunity against disease decrease in which ojokshya is a characteristic features. When there is a depletion or ojokshaya and resulting in loss of tissue strength, body strength and decrease in the resistance of body and increased susceptibility to various disease. Pramanta kshaya of oja or diminution of oja indicated pratyakhya.

Keywords: Ojas, Immunodefecient disorder, ojokshaya, ojovikara.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More